Renaissance Technologies - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 25 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2021$773,000
+8488.9%
822,655
+4708.3%
0.00%
Q2 2020$9,000
-91.7%
17,109
-56.0%
0.00%
Q2 2016$109,000
-38.4%
38,907
+34.6%
0.00%
Q1 2016$177,000
+124.1%
28,900
+97.9%
0.00%
Q4 2015$79,00014,6000.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q4 2015
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders